✓
Open
31 Jan to 6 Feb, 2020
✓
Close
31 Jan to 6 Feb, 2020
3
Allotment
—
✓
Listing
Fri, Feb 14, 2020
Price Band
₹51 per share
Issue Size
20,00,000 shares (agg. up to ₹10 Cr)
Lot Size
2,000 Shares
Listing Date
Fri, Feb 14, 2020
Latest GMP
₹0
Est. Gain
0%
✦ AI Insight
GMP Trend
16-01-2026₹0Est. ₹—+0%
15-01-2026₹0Est. ₹—+0%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 1.57x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Jul 2019 | 31 Mar 2019 | 31 Mar 2018 | 31 Mar 2017 |
|---|---|---|---|---|
| Assets | 85.94 | 82.86 | 58.06 | 55.90 |
| Total Income | 33.45 | 106.72 | 97.73 | 90.28 |
| Profit After Tax | 0.25 | 0.63 | 1.03 | 0.66 |
| EBITDA | 1.47 | 4.67 | 4.75 | 4.39 |
| NET Worth | 13.53 | 13.28 | 8.01 | 7.41 |
| Reserves and Surplus | 9.26 | 13.70 | 8.03 | 6.99 |
| Total Borrowing | 15.01 | 17.63 | 17.22 | 10.62 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Par Drugs & Chemicals Ltd. | SME | ₹8.53 Cr | ₹51 | null | ₹50.45 | -1.08% | ₹95.03 (-7.07%) |
| Cian Healthcare Ltd. | SME | ₹37.92 Cr | ₹61 | null | ₹61.50 | +0.82% | ₹9.55 (+4.95%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Incremental Working Capital Requirements | 7.00 |
| 2 | Setting up Distribution and Warehousing Centre’s | 1.50 |
| 3 | General Corporate Purpose | 0.95 |
| 4 | To meet Public Issue Expenses | 0.75 |
About Chandra Bhagat Pharma IPO
Incorporated in 2003, Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. They provide pharmaceuticals and special chemical products in the Indian and international market. The company has own sales force and distribution network to work under the brand name and supply products to the Health care center and Hospital. Chandra Bhagat Pharma also deals in import, supply and indenting in Active Pharmaceuticals Ingredients (API) and the intermediate. The company has FDA approval to get formulations manufactured from a contract manufacturer. It has a presence for formulations in some therapeutic categories such as Anesthesia, Cardiovascular, Anti-cancer (Oncology), Pediatrics, Nephrology, Antiviral, Anti-fungal, and Neurology. The warehouses/ storage houses of the company are on lease agreements at Bhiwandi- Thane, Maharashtra. Chandra Bhagat Pharma also exports Pharmaceutical Formulations to other countries like DR Congo, Bolivia and Philippines. Competitive Strengths1. Customer centric and order driven business model2. Relationships with MNCs3. Wide product portfolio inclu
Contact Details
Chandra Bhagat Pharma Ltd. Address323-F Bhagat BhuvanDr.Ambedkar RoadMatunga (East)Mumbai, Maharashtra, 400019+91 22 2414 6154compliance@cbcpharma.netVisit Website